Rational Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-2,060
| Closed | -$1.69M | – | 295 |
|
2023
Q1 | $1.69M | Buy |
+2,060
| New | +$1.69M | 0.14% | 66 |
|
2021
Q1 | – | Sell |
-1,800
| Closed | -$870K | – | 222 |
|
2020
Q4 | $870K | Buy |
1,800
+1,778
| +8,082% | +$859K | 0.23% | 107 |
|
2020
Q3 | $12K | Sell |
22
-6
| -21% | -$3.27K | 0.01% | 268 |
|
2020
Q2 | $17K | Buy |
+28
| New | +$17K | 0.01% | 301 |
|
2020
Q1 | – | Sell |
-24
| Closed | -$9K | – | 443 |
|
2019
Q4 | $9K | Sell |
24
-236
| -91% | -$88.5K | ﹤0.01% | 457 |
|
2019
Q3 | $72K | Buy |
260
+180
| +225% | +$49.8K | 0.03% | 322 |
|
2019
Q2 | $25K | Sell |
80
-5,017
| -98% | -$1.57M | 0.01% | 418 |
|
2019
Q1 | $2.09M | Buy |
5,097
+5,073
| +21,138% | +$2.08M | 0.57% | 65 |
|
2018
Q4 | $9K | Buy |
24
+22
| +1,100% | +$8.25K | ﹤0.01% | 395 |
|
2018
Q3 | $1K | Sell |
2
-1
| -33% | -$500 | ﹤0.01% | 507 |
|
2018
Q2 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 488 |
|
2015
Q3 | $12K | Hold |
25
| – | – | ﹤0.01% | 311 |
|
2015
Q2 | $13K | Hold |
25
| – | – | ﹤0.01% | 314 |
|
2015
Q1 | $11K | Sell |
25
-16
| -39% | -$7.04K | ﹤0.01% | 337 |
|
2014
Q4 | $17K | Buy |
+41
| New | +$17K | ﹤0.01% | 366 |
|
2013
Q4 | $667K | Buy |
2,423
+646
| +36% | +$178K | 0.06% | 318 |
|
2013
Q3 | $556K | Sell |
1,777
-73
| -4% | -$22.8K | 0.04% | 373 |
|
2013
Q2 | $416K | Buy |
+1,850
| New | +$416K | 0.03% | 403 |
|